IP Library Granted Patent US 9,890,401
Granted Patent B2
US 9,890,401 · App. 14/720,240 · Granted Feb 13, 2018

Methods and compositions for producing fatty alcohols

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,890,401
App. No.
14/720,240
Granted
Feb 13, 2018
Kind
B2
Abstract

Methods and compositions, including nucleotide sequences, amino acid sequences, and host cells, for producing fatty alcohols are described.

Claims (16)

1. A bacterial cell genetically engineered to express an exogenous polypeptide consisting of the amino acid sequence of SEQ ID NO: 22 and an exogenous polypeptide consisting of alcohol dehydrogenase activity, wherein the polypeptide having enzymatic activity consisting of alcohol dehydrogenase activity is selected from the group consisting of alrAadp1, yahK, yjgB, adhP, dkgA, dkgB, yhdH, ydjL, ydjJ, and yphC.

2. The bacterial cell of claim 1 , wherein the cell is further engineered to express an exogenous polypeptide having thioesterase (EC 3.1.2.14 or EC 3.1.1.5) activity.

3. The bacterial cell of claim 2 , wherein acyl-CoA dehydrogenase (fadE; EC 1.3.99.3, EC 1.3.99.-) expression or activity is attenuated in the bacterial cell as compared to a wild-type bacterial cell.

4. The bacterial cell of claim 2 , wherein acyl-CoA dehydrogenase (YdiO; EC 1.3.99.-) expression or activity is deleted or reduced in the bacterial cell as compared to a wild-type bacterial cell.

5. The bacterial cell of claim 2 , wherein fadA (EC 2.3.1.16) expression or activity is deleted or reduced in the bacterial cell as compared to a wild-type bacterial cell.

6. The bacterial cell of claim 2 , wherein fadB (EC 4.2.1.17, EC 5.1.2.3, EC 5.3.3.8, EC 1.1.1.35) or fadJ (EC 4.2.1.17, EC 5.1.2.3, EC 1.1.1.35) expression or activity is deleted or reduced in the bacterial cell as compared to a wild-type bacterial cell.

7. The bacterial cell of claim 1 , wherein the bacterial cell is an E. coli cell.

8. A method of producing a fatty alcohol composition comprising C12 and C14 fatty alcohols, the method comprising culturing the bacterial cell of claim 1 in culture media containing a carbohydrate carbon source under conditions that promote expression of the polypeptide of SEQ ID NO: 22.

9. The method of claim 8 , wherein the cell is further engineered to express an exogenous polypeptide having thioesterase (EC 3.1.2.14 or EC 3.1.1.5) activity.

10. The method of claim 9 , wherein the cell is further engineered to have acyl-CoA dehydrogenase (fadE; EC 1.3.99.3, 1.3.99.-) expression or activity is attenuated.

11. The method of claim 9 , wherein the cell is further engineered to have acyl-CoA dehydrogenase (YdiO; EC 1.3.99.-) expression or activity is deleted or reduced.

12. The method of claim 9 , wherein the cell is further engineered to have 3-ketoacyl-CoA thiolase (fadA; EC 2.3.1.16) expression or activity deleted or reduced.

13. The method of claim 9 , wherein the cell is further engineered to have fadB (EC 4.2.1.17, EC 5.1.2.3, EC 5.3.3.8, EC 1.1.1.35) expression or activity deleted or reduced.

14. The method of claim 9 , wherein the cell is further engineered to have beta-ketoacyl-CoA thiolase (fadI; EC 2.3.1.16) expression or activity deleted or reduced.

15. The method of claim 9 , wherein the cell is further engineered to have fadJ (EC 5.1.2.3, EC 4.2.1.17, EC 1.1.1.35) expression or activity deleted or reduced.

16. The method of claim 8 , wherein the bacterial cell is an E. coli cell.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2019
From: REG LIFE SCIENCES, LLC
To: GENOMATICA, INC.
Reel/Frame 050695/0661 →